HALE DAVID F purchased 3.4% of their position (980.00 shares) of ONCTERNAL THERAPEUTICS, INC. on the open market
Open‑market purchase worth $8.9K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 2/27/2024ACC: 0001209191-24-004016
+980.00
Net shares
Net buyer
$8.9K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
980.00 acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+714.00
Price / share
$9.04
Trade value
$6.45K
% of position
New position
2/23/2024
0.00→714.00
Common Stock
Indirect
Shares
+266.00
Price / share
$9.04
Trade value
$2.40K
% of position
0.9%
2/23/2024
29.41K→29.67K
Total
Net shares
+980.00
Net value
$8.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2024 | P · Purchase | +714.00 | $9.04 | $6.45K | New position | 0.00 | 714.00 |
| Common Stock Indirect | 2/23/2024 | P · Purchase | +266.00 | $9.04 | $2.40K | 0.9% | 29.41K | 29.67K |
| Total | +980.00 | $8.86K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned917.00
Total
917.00 indirect917.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 917.00 | Indirect |
| Total | 917.00 | 917.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported